Product Information
CEFDINIR 300 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.4581 per EA under NDC 57237009960. Its NADAC has been published 589 times since Mar 18, 2015.
Strength
300 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237009960
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA065434On Market Since
1/7/2008
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 300 MG CAPSULE has been published 589 times since Mar 18, 2015, and over the history we have for it it has declined 65.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4581 per EA |
|---|---|
| All-time high | $1.3376 (Apr 15, 2015) |
| All-time low | $0.3507 (Nov 20, 2024) |
| 52-week high | $0.4752 |
| 52-week low | $0.4551 |
| Median price | $0.4919 |
| Average price | $0.5694 |
| Largest weekly change | +50.2% (Feb 22, 2017) |
| Weeks tracked | 589 |
| Tracking since | Mar 18, 2015 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFDINIR 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 300 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.4581 per EA (NDC 57237009960), effective Jun 24, 2026.
How has the price of CEFDINIR 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFDINIR 300 MG CAPSULE has declined 65.7%. It has been tracked across 589 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for CEFDINIR 300 MG CAPSULE?
Since Mar 18, 2015, the NADAC for CEFDINIR 300 MG CAPSULE has ranged from a low of $0.3507 (Nov 20, 2024) to a high of $1.3376 (Apr 15, 2015), with a median of $0.4919 per EA.
Are there cheaper alternatives to CEFDINIR 300 MG CAPSULE?
7 NADAC-published products share the same active ingredient, strength, and dosage form as CEFDINIR 300 MG CAPSULE, but none are currently priced below it.
Who manufactures CEFDINIR 300 MG CAPSULE?
CEFDINIR 300 MG CAPSULE (NDC 57237009960) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification